Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 3/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.38 |
| ▸ | DRD1 | P21728 | 2/20 | 0.38 |
| ▸ | HTR2C | P28335 | 2/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.38 |
| ▸ | HRH1 | P35367 | 2/20 | 0.38 |
| ▸ | DRD3 | P35462 | 2/20 | 0.38 |
| ▸ | HTR2B | P41595 | 2/20 | 0.38 |
| ▸ | HTR3A | P46098 | 2/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.38 |
| ▸ | MLNR | O43193 | 1/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL50526 | 0.80 | CES1 (0.35) | CES1 | |
| SCHEMBL17068313 | 0.79 | CES1 (0.33) | PGRCES1 | |
| SCHEMBL9927262 | 0.78 | PTPRC (0.39) | PTPRCMEN1KMT2ACES1LMNA | |
| SCHEMBL17108437 | 0.75 | CES1 (0.33) | CES1 | |
| SCHEMBL283246 | 0.75 | HTR2A (0.48) | HTR2ACHRM2ADRA2ACHRM1ADRA2B | |
| SCHEMBL29363404 | 0.75 | HTR2A (0.48) | HTR2ACHRM2ADRA2ACHRM1ADRA2B | |
| SCHEMBL22503337 | 0.74 | CES1 (0.30) | CES1 | |
| SCHEMBL20850166 | 0.74 | ALDH1A1 (0.33) | MEN1KMT2ACYP1A2CYP3A4CYP2D6 | |
| SCHEMBL23568686 | 0.74 | TDP2 (0.33) | PDK2 | |
| SCHEMBL20850099 | 0.74 | CASP3 (0.37) | HTR2AHTR2CPGRLMNAPDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10370473-B2 | Compound, curable composition, cured product, optical member, and lens | FUJIFILM CORPORATION (JP) | 2019-08-06 | — | — | US | disclosed |
| US-8502209-B2 | Polymer compound and organic transistor using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-08-06 | — | — | US | disclosed |
| US-8502209-B2 | Polymer compound and organic transistor using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-08-06 | — | — | US | disclosed |
| US-20110073854-A1 | POLYMER COMPOUND AND ORGANIC TRANSISTOR USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-03-31 | — | — | US | disclosed |
| US-20110073854-A1 | POLYMER COMPOUND AND ORGANIC TRANSISTOR USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-03-31 | — | — | US | disclosed |
| EP-2289965-A1 | POLYMER COMPOUND AND ORGANIC TRANSISTOR USING THE POLYMER COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2011-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110073854-A1 | POLYMER COMPOUND AND ORGANIC TRANSISTOR USING THE SAME | TERT, NOXO1, TERB1 | PTPRC 2262/4885HTR2A 3983/4885CHRM2 988/4885 |
| US-10370473-B2 | Compound, curable composition, cured product, optical member, and lens | CRYZ, CRYAA, UACA | PTPRC 4576/4885HTR2A 3473/4885CHRM2 848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.